FDA Issues Safety Communication for Hip Replacement Devices

The U.S. Food and Drug Administration (FDA) issued a safety communication regarding the use of metal-on-metal hip replacement devices. The release warns both doctors and patients of the risks involved with the use of such devices and offers several tips to determine if the device is right for a patient.

A metal-on-metal hip replacement device consists of a ball and socket joint and a set of connecting rods that are made of strong, heavy metals. The problem with the devices though, is that they can prematurely wear. This can result in the patient experiencing adverse health events, including:

The concerns have led to the FDA and manufacturers taking actions such as the Stryker® Hip Implant Recall. DePuy Orthopedics, Inc. also made similar moves with their line of hip replacement products.

Those who have been affected by problems with these devices are taking legal action against the manufacturers of these failed products, claiming more testing should have been conducted on the devices before they were released onto the market. Those who were injured allege that such actions were negligent and that compensation should be given to those who were affected.

The Connecticut Personal Injury Lawyers with Carter Mario Law Firm is aware of the frustrations and difficulties a defective medical device can present to a patient. That’s why the firm suggests anyone who has been affected by a metal-on-metal hip replacement failure discuss their legal options with an attorney.